Norgestimate And Ethinyl Estradiol
Product Images NDC 50090-3733

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 50090-3733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-b (Figure B)

An instructional diagram showing a finger pointing to a circular tablet labeled for Sunday, with arrows indicating directions to Start and Week 2 on a weekly pill organizer. The image helps guide the user on where to begin taking medication, specifically for norgestimate and ethinyl estradiol tablets by A-S Medication Solutions.*

FDA Label Image

Figure-c (Figure C)

An instructional illustration titled 'Norgestimate and Ethinyl Estradiol Tablets USP' showing a 28-day pill pack for oral contraceptives with four weeks of circular tablet slots arranged in seven columns by days of the week. A hand is peeling back a protective cover labeled with days Tuesday to Saturday. The image includes dosing strengths 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg.*

FDA Label Image

Figure-d (Figure D)

An instructional illustration labeled Figure D showing a finger pressing a circular tablet in a weekly pill pack labeled with days Tuesday and Wednesday. The dosage strength displayed above the pack is Norgestimate 0.18 mg and Ethinyl Estradiol 0.025 mg. The image includes arrows indicating the start of the pack and the beginning of Week 2.*

FDA Label Image

Figure-e (Figure E)

An instructional diagram illustrating a pill pack layout for norgestimate and ethinyl estradiol by A-S Medication Solutions. It shows a four-week cycle with rows labeled Start, Week 2, Week 3, and Week 4, with two pill positions each labeled for Sunday and Monday. A finger is shown pressing the first pill in Week 4's Sunday slot.*

FDA Label Image

Pill-dispenser (Image 01)

FDA Label Image

Img3 (Img3)

An instructional diagram showing pregnancy rates per 100 women in one year in relation to different birth control methods. It ranks methods from fewer pregnancies, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones, to more pregnancies with no birth control. Intermediate methods include condoms, diaphragm, spermicides, withdrawal, and timing sex to avoid fertile days.*

FDA Label Image

Label Image (Lbl500903733)

The packaging label for norgestimate and ethinyl estradiol tablets, labeled by A-S Medication Solutions, shows Product No. 6838-0 with NDC 50090-3733-0. The label includes lot number and expiration date fields, dosage instructions (one tablet daily), and manufacturer details. The package contains one blister card with 28 tablets.*

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Logo (Logo)

FDA Label Image

Pill-dispenser (Pill Dispenser 01)

An instructional diagram for Norgestimate and Ethinyl Estradiol tablets USP illustrating a 28-day pill pack divided into four weeks. It shows white to off-white, light blue, and blue pills labeled as active, and green to dark green pills labeled as inactive, arranged by day of the week from Sunday to Saturday each week. The diagram includes a note about the package not being child resistant.*

FDA Label Image

Structures (Structures)

Chemical structure diagrams of norgestimate USP and ethinyl estradiol USP, the active ingredients in the combination product labeled by A-S Medication Solutions with NDC 50090-3733.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.